Cetuximab less effective in simple tumors
Friday, June 11, 2010 - 07:31
in Health & Medicine
ROCHESTER, Minn., June 11 (UPI) -- A U.S. clinical trial has found a drug of benefit to metastatic colon cancer patients fails to help patients with less advanced Stage III tumors.